|
|
||||||||
RESEARCH REPORT |
1 Department of Periodontics, School of Dentistry, University of Washington, D322-Health Science Center Box 356365, Seattle, WA 98195-6365, USA;
2 Division of Periodontology and Endodontology, Tohoku University Graduate School of Dentistry, Sendai 980-8575, Japan; and
3 FBDC-Curso de Odontologia, Brazil
* corresponding author, somerman{at}u.washington.edu
| ABSTRACT |
|---|
|
|
|---|
B ligand (RANKL), interleukin-6, Regulated on activation, normal T-cell expressed, and secreted (RANTES), macrophage inflammatory protein-1
, and monocyte chemoattractant protein-1 were rapidly and dramatically induced upon stimulation with PgLPS1690, but only slightly induced with PgLPS1435/1449. Osteoprotegerin, which was expressed constitutively, was not altered significantly. ELISA demonstrated synthesis of corresponding proteins. PgLPS1690 significantly induced transcripts for NF-
B, and this activation was inhibited by pre-treatment with anti-TLR-2 but not with TLR-4 antibodies. These results suggest that cementoblasts participate in the recruitment of osteoclastic precursor cells by up-regulation of chemokines/cytokines.
KEY WORDS: cementoblast osteoclastogenesis Toll-like receptor lipopolysaccharide Porphyromonas gingivalis
| INTRODUCTION |
|---|
|
|
|---|
B ligand (RANKL) is up-regulated, and the expression of osteoprotegerin (OPG), which acts as a decoy receptor for RANKL, is down-regulated (Kikuchi et al., 2001; Suda et al., 2004). Furthermore, interleukin (IL)-6, which functions in the induction of osteoclast activity and subsequent bone resorption (Kotake et al., 1996), is released by osteoblasts upon stimulation with E. coli LPS (Kwan Tat et al., 2004). Moreover, osteoblasts release a series of chemokinessuch as monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1
, RANTES (Regulated on activation, normal T-cell expressed, and secreted)that recruit osteoclast precursors and directly enhance osteoclast formation through a pathway dependent on the presence of RANKL (Jiang and Graves, 1999; Yu et al., 2004; Kim et al., 2005). In contrast to the observation of significant destruction of bone with inflammatory conditions of the oral cavity, root resorption is rarely seen under inflammatory conditions. Cementum is a thin mineralized tissue covering the tooth root surface and an important component of the periodontal attachment apparatus. Although cementum shares many properties with bone, most notably a remarkable similarity in biochemical composition, it has yet to be established whether cementoblasts and osteoblasts have a common precursor cell. Cementum differs from bone in its histology by lacking innervation and vascularization. Furthermore, cementum has limited remodeling potential when compared with bone, where a system consisting of osteoblasts, osteocytes, bone-lining cells, and osteoclasts is required (Saygin et al., 2000; Bosshardt, 2005).
Our laboratory developed an immortalized murine cementoblast cell line (OCCM-30) that reflects genes and proteins associated with these cells in situ, such as expression of bone sialoprotein, osteocalcin (OCN), and type I collagen (DErrico et al., 2000). Previously, we reported that, similar to osteoblasts, OCCM-30 expresses Toll-like receptor (TLR) -2 and -4, and that, further, upon exposure of OCCM-30 to P. gingivalis LPS, genes associated with cementum formation are altered (Nociti et al., 2004). P. gingivalis LPS has been reported to contain an unusual amount of lipid A heterogeneity (Darveau et al., 2004), and has been shown to have the ability to utilize TLR-2 or TLR-4 (Hajishengallis et al., 2002; Zhou et al., 2005). We have generated two different structural types of lipid A, tetra- and penta-acylated lipid A species designated PgLPS1435/1449 and PgLPS1690, respectively (Reife et al., 2006).
These observations led us to investigate whether PgLPS1690 and PgLPS1435/1449 affect osteoclastogenesis-associated gene expression of cementoblasts.
| MATERIALS & METHODS |
|---|
|
|
|---|
Cells
An immortalized murine cementoblast cell line, OCCM-30, was established by the isolation of tooth root-surface cells from transgenic mice containing an SV40 large T-antigen under the control of the OCN promoter (DErrico et al., 2000). Cells were maintained in DMEM (Gibco, Rockville, MD, USA) plus 10% FBS and antibiotics. All procedures were approved by the University of Washington, Committee on Use and Care of Animals, and were in compliance with state and Federal laws.
Purification of PgLPS1435/1449 and PgLPS1690
The PgLPS1435/1449 was purified from P. gingivalis ATCC 33277 by the MgCl2/ETOH procedure (Darveau et al., 2004). PgLPS1690 was obtained by the phenol water procedure (Westphal and Jann, 1965) and treated for the removal of trace amounts of endotoxin protein, and then subjected to SDS-PAGE and stained for protein by the enhanced colloidal gold procedure (Manthey and Vogel, 1994). The colloidal gold procedure revealed less than 0.1% protein contamination, based upon the amount of LPS loaded onto the gel and the relative intensity of the major protein band to known BSA standards. Gas chromatography/mass spectrometry of the fatty acids present in the PgLPS1690 preparation was performed, and the identification of all the peaks found in the preparation after transmethylation was performed by identification of the mass spectral patterns (Darveau et al., 2004). Matrix-assisted laser desorption-time-of-flight mass spectroscopy was performed (Guo et al., 1997) and revealed one major cluster of lipid A structures centered around a mass of PgLPS1690.
Reverse Transcription and Real-time Quantitative PCR
Total cellular RNA was extracted with the use of Trizol® reagent (Gibco) according to the manufacturers instructions, and was DNase-treated (DNA-freeTM, Ambion Inc., Austin, TX, USA). The transcription of total RNA into cDNA was carried out with the use of a Transcriptor First Strand cDNA Synthesis Kit® (Roche Diagnostic Co., Indianapolis, IN, USA) according to the manufacturers instructions. Primers were designed with the use of LightCycler probe design software (Roche Diagnostics GmbH, Mannheim, Germany), and primer sequences for each gene, IL-6, MCP-1, MIP-1
, RANTES, RANKL, OPG, and GAPDH were as follows (forward/reverse): IL-6 (ACTGATGCTGGTGACA/GC AAGTGCATCATCGT); MCP-1 (CTCGGGCAGCTAGAAT/GG CGTTGTGATGCAAA); MIP-1
(GGAAGATTCCACGCCAA/CCTCGATGTGGCTACT); RANTES (GAAGGAACCGCC AAGT/CCGATTTTCCCAGGACC); RANKL (CATCGGGTT CCCATAAAGTC/TTGCCCGACCAGTTTTTC); OPG (TGAATGCCGAGAGTGTAG/CTGCTCGCTCGATTTG); GAPDH (ACCACAGTCCATGCCATCAC/TCCACCACCCTGTTGCTGTA). The amplification profile was 95/0; 55/7; 72/20 [temperature (°C)/time (sec)], with a slope of 20°C/sec and 43 cycles. PCR was performed in a LightCycler system (Roche Diagnostic GmbH) with the FastStart DNA Master SYBR Green I kit (Roche Diagnostic Co.), with optimization of 3 mM MgCl2 and 0.5 µM primer. Reaction product was quantified (Roche Quantification Software, Roche Diagnostics GmbH) with GAPDH as the reference gene.
Preparation of Cell Lysates
Confluent cells cultured in 35-mm-diameter culture dishes were harvested with a cell scraper and subjected to lysis in 100 µL of cell lysis buffer (10 mM phosphate buffer [pH 7.0], 150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 0.1% SDS, 1 mM PMSF). After lysis, cells were incubated on ice for 30 min, followed by centrifugation at 12,000 x g for 10 min, and then the supernatants were collected and stored at 20°C. The protein concentration of cell lysates was measured by DC Protein Assay® (Bio-Rad Laboratories, Hercules, CA, USA).
Enzyme-linked Immunosorbent Assay (ELISA)
Supernatants from cell cultures were harvested by centrifugation, and kept at 20°C. The amounts of OPG, MCP-1, IL-6, RANTES, and MIP-1µ in the supernatants and RANKL in the cell lysate (50 µg) were measured by means of mouse ELISA kits (R&D Systems Inc., Minneapolis, MN, USA). The assays were performed precisely as instructed by the ELISA manufacturer.
NF-
B Luciferase Assay
The NF-
B firefly luciferase reporter construct pNF-
B-TA-Luc was obtained from BD Bioscience Clontech (Palo Alto, CA, USA). The ß-actin-Renilla luciferase reporter construct was generously provided by C. Wilson (University of Washington, Seattle). Cells were seeded in a 24-well plate at a density of 1 x 105 cells per well one day before transfection. The cells were transiently co-transfected with 0.4 µg of pNF-
B-TA-Luc and 0.01 µg of pß-actin-Renilla Luc by means of LipofectAMINE2000TM (Invitrogen, San Diego, CA, USA) as described previously (Coats et al., 2003). Eighteen hours after the transfection, the transfected cells were stimulated with activators as indicated in the text. Following 5 hrs of stimulation in DMEM with 10% FBS, the cells were rinsed with PBS, subjected to lysis with 100 µL of passive lysis buffer, and analyzed with a Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) as instructed by the manufacturer. Data are presented as means ± standard deviations (SD) of triplicate experiments.
Statistical Analysis
Experimental values are given as means ± SD. The significance of differences between control and treatments was evaluated by one-way ANOVA.
| RESULTS |
|---|
|
|
|---|
protein levels were rapidly (36 hrs) and significantly induced after stimulation with PgLPS1690, with only slight induction upon stimulation with PgLPS1435/1449 noted. OPG protein levels were induced over time in untreated cells, with no changes by either PgLPS1690 or PgLPS1435/1449 (Fig. 2
|
|
B Activation
B-luciferase reporter construct, and blocking experiments with mAbs were performed. E. coli LPS and peptidoglycan were used as specific ligand controls for TLR-4 and TLR-2, respectively. NF-
B activation by E. coli LPS was significantly inhibited by TLR-4 mAb, which neutralized TLR-4 signaling (Kikuchi et al., 2001), and activation by peptidoglycan was completely inhibited by TLR-2 mAb. NF-
B activation by PgLPS1690 was almost completely inhibited by TLR-2 mAb, but not by TLR-4 mAb, and, further, the combination of both mAbs showed no additional effect (Fig. 3
B activation was induced slightly. These results indicate that PgLPS1690 and PgLPS1435/1449 acted on cementoblasts through a TLR-2-dependent pathway. Next, we examined whether the changes in gene expression mediated by P. gingivalis LPS were inhibited by TLR-2 mAb. PgLPS1690-mediated induction of RANKL, IL-6, and RANTES was markedly inhibited by pre-treatment with TLR-2 mAb, but not with TLR-4 mAb. Pre-treatment with both mAbs showed no additional effect. Although the induction of these genes by PgLPS1435/1449 was weak, a similar inhibitory pattern was observed (Fig. 4
|
|
| DISCUSSION |
|---|
|
|
|---|
Previous studies with murine osteoblasts have shown that the expression of RANKL is rapidly induced upon stimulation by E. coli LPS via TLR-4 (Kikuchi et al., 2001; Suda et al., 2004). Analysis of existing data indicates that osteoblasts have the potential to release various chemokines/cytokines when stimulated with pro-inflammatory cytokines or LPS. These chemokines/cytokines have been shown to induce osteoclastogenesis directly or indirectly by the mechanism described previously in the INTRODUCTION. Our findings indicated that, when cementoblasts were exposed to inflammatory stimuli, they responded in a similar fashion to osteoblasts in terms of stimuli-mediated induction of proteins/genes associated with osteoclast activation, as well as the recruitment of osteoclastic precursors, suggesting that cementoblasts have the potential to enhance osteoclastogenesis during periodontal disease in a manner comparable with that of osteoblasts.
However, and in seeming contrast to osteoblasts, two lines of evidence indicate that cementoblasts may protect the tooth root surface from resorption during times of local LPS challenge. First, it was shown that OPG was expressed by cementoblasts constitutively, and the gene and protein levels were not altered upon stimulation with LPS. In contrast, OPG expressed by osteoblasts has been reported to be suppressed by E. coli LPS (Suda et al., 2004), rendering this cell type less effective for inhibiting bone or tooth resorption. This is unlikely to represent a TLR-2 vs. TLR-4 phenomenon, considering that E. coli and P. gingivalis LPS exhibited similar effects in terms of RANKL/OPG. Second, the rapid appearance of RANKL and slow increase in OPG by cementoblasts suggest that RANKL-dependent osteoclast formation mediated by MIP1-
and RANTES (Yu et al., 2004) may be inhibited further, preventing osteoclast formation near the tooth root surface. In addition, osteoclasts from the blood may favor migration to the well-vascularized surrounding bone vs. the avascular cementum. These results are consistent with the clinical observations that osteoclast-mediated root resorption is rarely linked to periodontal disease, even at a stage of severe disease with marked bone loss. Therefore, differences in the regulation of OPG by osteoblasts vs. cementoblasts, while speculative at this point, may be related to protection of the tooth root surface in response to LPS. Future studies, using a co-culture system of osteoclastic precursors with cementoblasts or other cell types, including osteoblasts, in the presence or absence of LPS, may enable us to verify the validity of our hypothesis.
TLR-4 is the principal signal transducer for most types of LPS, while analysis of existing data suggests that TLR-2 is a signal transducer for other bacterial components, such as peptidoglycan and lipoprotein (Takeuchi et al., 1999). However, P. gingivalis LPS is unusual, in that it has been reported to be an agonist for both TLR-2 and -4 (Hajishengallis et al., 2002; Darveau et al., 2004; Zhou et al., 2005). Here, it was shown that both the PgLPS1435/1449 and PgLPS1690 activated NF-
B in cementoblasts through the TLR-2 pathway. In another ongoing study from our group, we observed that PgLPS1690 stimulated E selectin expression on human endothelial cells, whereas PgLPS1435/1449 did not, and, furthermore, that it blocked E selectin expression in response to PgLPS1690 (Reife et al., 2006). These findings demonstrate that the different P. gingivalis LPS lipid A structural types activate different cementoblast activation pathways.
In conclusion, we report for the first time that cementoblasts potentially participate in the recruitment of osteoclastic precursors by inducing chemokines/cytokines during periodontitis. In addition, constant expression of OPG in cementoblasts may play a critical role in protecting the tooth from osteoclast activity under physiological conditions such as stress associated with mastication, as well as under pathological conditions.
| ACKNOWLEDGMENTS |
|---|
Received February 7, 2006; Last revision April 30, 2006; Accepted May 11, 2006
| REFERENCES |
|---|
|
|
|---|
Coats SR, Reife RA, Bainbridge BW, Pham TT, Darveau RP (2003). Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at Toll-like receptor 4 in human endothelial cells. Infect Immun 71:67996807.
DErrico JA, Berry JE, Ouyang H, Strayhorn CL, Windle JJ, Somerman MJ (2000). Employing a transgenic animal model to obtain cementoblasts in vitro. J Periodontol 71:6372.[ISI][Medline]
Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, et al. (2004). Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect Immun 72:50415051.
Guo L, Lim KB, Gunn JS, Bainbridge B, Darveau RP, Hackett M, et al. (1997). Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250253.
Hajishengallis G, Martin M, Schifferle RE, Genco RJ (2002). Counteracting interactions between lipopolysaccharide molecules with differential activation of Toll-like receptors. Infect Immun 70:66586664.
Hikita A, Kadono Y, Chikuda H, Fukuda A, Wakeyama H, Yasuda H, et al. (2005). Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding. J Biol Chem 280:4170041706.
Holt SC, Kesavalu L, Walker S, Genco CA (1999). Virulence factors of Porphyromonas gingivalis. Periodontol 2000 20:168238.
Jiang Y, Graves DT (1999). Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone-derived cells. J Periodontol 70:14721478.[ISI][Medline]
Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, et al. (2001). Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166:35743579.
Kim MS, Day CJ, Morrison NA (2005). MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 280:1616316169.
Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, et al. (1996). Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11:8895.[ISI][Medline]
Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y (2004). IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:4960.[ISI][Medline]
Manthey CL, Vogel SN (1994). Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res 1:8491.
Nociti FH Jr, Foster BL, Barros SP, Darveau RP, Somerman MJ (2004). Cementoblast gene expression is regulated by Porphyromonas gingivalis lipopolysaccharide partially via Toll-like receptor-4/MD-2. J Dent Res 83:602607.
Reife RA, Coats SR, Al-Qutub M, Dixon DM, Braham PA, Billharz RJ, et al. (2006). Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cell Microbiol 8:857868.[ISI][Medline]
Saygin NE, Giannobile WV, Somerman MJ (2000). Molecular and cell biology of cementum. Periodontol 2000 24:7398.
Socransky SS, Haffajee AD (1992). The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 63:322331.[ISI][Medline]
Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo JT, et al. (2004). Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172:25042510.
Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443451.[ISI][Medline]
Westphal O, Jann K (1965). Bacterial lipopolysaccharide: extraction with phenol-water and further applications of the procedure. In: Methods in carbohydrate chemistry. Whistler RL, editor. New York: Academic Press Inc., p. 83.
Yu X, Huang Y, Collin-Osdoby P, Osdoby P (2004). CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19:20652077.[ISI][Medline]
Zhou Q, Desta T, Fenton M, Graves DT, Amar S (2005). Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 73:935943.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |